Full Breakdown
Federal Crackdown on Hospice Fraud in California
4/2/2026, 8:51:39 PM
Overview of the Investigation
On April 2, 2026, federal authorities arrested a married couple, Gladwin and Amelou Gill, accused of fraudulently billing Medicare for $7.45 million while operating 626 Hospice, also known as St. Francis Palliative Care. The arrests were part of a broader initiative dubbed "Operation Never Say Die," targeting a network of fraudulent hospice operations in Southern California. The Gills' hospice reportedly had a survival rate of over 97% after five years, raising red flags among investigators, as most hospice patients are in the final stages of terminal illnesses.
Scale of the Problem
The investigation revealed that over 700 of the approximately 1,800 hospices in Los Angeles County exhibited multiple indicators of fraud, including low patient counts, excessive billing, and shared staff across multiple facilities. A notable example is a single office plaza housing 89 registered hospices, described by patient advocate Sheila Clark as "ground zero" for Medicare hospice fraud. The Department of Health and Human Services reported that suspected hospice fraud amounted to an estimated $198.1 million nationwide in 2023.
Political Context and Responses
The issue of hospice fraud has garnered significant political attention, particularly from Republican leaders. Vice President JD Vance, who leads an anti-fraud task force, emphasized the administration's commitment to addressing this issue, stating that the number of suspended providers in California has dramatically increased from 70 to 221 in just a week. The House Oversight Committee has initiated an investigation into California's hospice programs, alleging a lack of sufficient oversight and internal controls to prevent fraud.
California Attorney General Rob Bonta has also taken action, filing criminal cases against over 100 defendants in the hospice industry. He acknowledged the need for more proactive measures, stating, "We need to be responsive to the red flags and react to them, not just count them."
Criticism and Opposition
Despite the ongoing investigations, California Governor Gavin Newsom's administration has faced criticism for its handling of hospice fraud. In response to allegations of inadequate oversight, Newsom's office claimed that California has been actively combating hospice fraud for years, revoking over 280 licenses and implementing a moratorium on new hospice providers. However, Republican critics argue that the state's efforts have been insufficient, pointing to the alarming increase in fraudulent activities.
Conflicting Reports and Gaps
While the federal crackdown has led to numerous arrests and suspensions, discrepancies remain regarding the extent of fraud in California's hospice system. Some reports indicate that the Gills' hospice had a mortality rate of just 2.3%, while others highlight cases of providers billing Medicare for patients who were not terminally ill. Additionally, the investigation into Dr. Fariba Javaherian, who allegedly billed $35 million for hospice care, raises questions about the legitimacy of her claims of identity theft.
What's Next
The federal government plans to continue its audits of high-billing hospice agencies nationwide to recover lost taxpayer funds. The ongoing investigations will likely lead to further arrests and regulatory changes aimed at preventing future fraud in the hospice sector.
Verbatim Quotes
- “Hospice is an entirely different level of fraud,” — Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services
- “We need to be responsive to the red flags and react to them, not just count them,” — Rob Bonta, California Attorney General
- “The Administration's War on Fraud once again yields results as more suspensions take place and fraudsters face justice for ripping off hard-working Americans and stealing their tax dollars and social services,” — JD Vance, Vice President
This comprehensive investigation highlights the urgent need for enhanced oversight and accountability in the hospice industry, as federal and state authorities work to root out fraudulent practices that exploit vulnerable patients and taxpayers.
